May 8, 2024 · Velcade injection is a proteasome inhibitor, a type of targeted cancer drug. Velcade injection is not chemotherapy. Velcade works by blocking enzymes (proteasomes), which …

Mar 7, 2025 · Velcade® (bortezomib) is an injectable anti-cancer agent used in various stages of multiple myeloma. See potential side effects and other information.

Bortezomib, sold under the brand name Velcade among others, is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma. [4] This includes multiple myeloma in …

May 9, 2022 · Velcade (bortezomib) is a recommended anticancer treatment option for multiple myeloma and mantle cell lymphoma in adults. It's given as an injection under the skin …

Oct 6, 2024 · Overview: Bortezomib (Velcade, Boruzu) is used to treat certain blood cancers, including multiple myeloma and mantle cell lymphoma.

Velcade (bortezomib) is a proteasome inhibitor for patients with multiple myeloma or mantle cell lymphoma. See its full prescribing information.

VELCADE (bortezomib) for Injection is indicated for the treatment of patients with mantle cell lymphoma who have received at least 1 prior therapy. VELCADE (bortezomib) is administered …

Mar 11, 2024 · Bortezomib works by inhibiting the 26S proteasome. A proteasome is an enzyme that is responsible for breaking down proteins in all cells (healthy or cancerous). By blocking …

It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells. This medicine may be used for other purposes; ask your …

Velcade® represents a new type of anticancer drug called proteasome inhibitors. It has shown promise in the treatment of multiple myeloma, a cancer of the white blood cells. Velcade® is …